Diamyd Medical AB (publ) (DYMDF) Discusses Surprising Futility Results in Phase III Trial of Retogatein for Type 1 Diabetes Transcript By Sigma Hunter · March 30, 2026 · 1 min read dymdfsa transcripts Source: seekingalpha.com